Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy response
Year: 2025
Type: article
Study design: Observational Study
Source: Lara D. Veeken
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4413309186
